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The Kidney Disease Outcomes Quality Initiative (K/DOQI)
guidelines suggest that clinicians use the estimated
glomerular filtration rate (eGFR) measurements and minimize
the use of timed urine creatinine clearance collection. The
intent of this change was to improve recognition of chronic
kidney disease. Here we used time-series modeling and
intervention analyses to determine the effect of publication
of the K/DOQI guidelines and the introduction of widespread
eGFR reporting with prompts on physician ordering of
24-h urine collection for creatinine clearance. In this setting,
clinical practice guidelines did not influence creatinine
clearance testing; however, the direct introduction of eGFR
reporting with prompts into physician workflow resulted
in a sudden and significant 23.5% decrease in creatinine
clearance collection over the 43 months analyzed. Thus,
eGFR reporting with prompts may have produced a clinical
practice change because it is integrated directly into
physician workflow. Changing physician practice patterns
may require more than publishing guidelines; rather it is
more likely to occur through educational and structural
changes to practice.
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In medical practice, guidelines are developed to standardize
practice patterns and ensure that patients receive effective
and up-to-date evidence-based medicine.1 Nevertheless, clinical
guidelines often have little impact on physician practices,2–4 and
investigations of the effects of renal practice guidelines are
limited.5–9
In February 2002, the National Kidney Foundation
published the Kidney Disease Outcomes Quality Initiative
(K/DOQI) Clinical Practice Guidelines for chronic kidney
disease.10 These guidelines recommended the use of esti-
mated glomerular filtration rate (eGFR) equations to
estimate a patient’s renal function. Furthermore, the use of
timed urine collection (i.e., 24-h urine collection for
creatinine clearance (CrCl)) was discouraged because of its
imprecision and inconvenience when compared with eGFR.
CrCl was to be reserved for patients with exceptional dietary
intake, poor muscle mass, or to assess nutritional status or
patient need for dialysis.
In January 2006, all outpatient laboratories in Ontario,
Canada, began to report eGFR values with prompts (see
Supplementary Material online) whenever a serum creatinine
test was ordered.11 That same year, the Canadian Society of
Nephrology endorsed the routine usage of eGFR reporting in
CKD.12 As described elsewhere, there were no province or
nationwide active educational efforts that coincided with the
introduction of eGFR reporting.8 The aim for this change in
reporting was to improve recognition of CKD. Previous studies
have shown that eGFR reporting was associated with increased
nephrology consults and an improvement in the detection of
previously under-recognized populations.8,11 We sought to
determine the effects of the publication of the K/DOQI
guidelines and the population-wide introduction of eGFR
reporting with prompts on physician requests for CrCl
collection. Such results would help us better understand the
influence of such initiatives on clinical practice.
RESULTS
On average, data from 8.4 million individuals per month
were available. The data (Figure 1) were predictably seasonal
with nadirs in CrCl collection rates occurring around the
winter holiday period.
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Impact of K/DOQI guidelines on CrCl collections
Before publication of the K/DOQI guidelines, the average
rate of CrCl collection per month was 42.3 per 100,000 adult
population. After publication, this was essentially unchanged
(46.2 per 100,000). In other words, the publication of the
K/DOQI guidelines was not associated with a significant
change in the sex- and age-adjusted rate of CrCl tests
performed (P¼ 0.82).
Impact of eGFR reporting with prompts on CrCl collections
Before eGFR reporting with prompts, the average rate of CrCl
collection per month was 44.6 per 100,000 adult population.
After implementation, this changed to 34.1 per 100,000 adult
population per month. This represented a 23.5% absolute
decrease in the number of tests performed per month. The
initiation of eGFR reporting with prompts was associated
with a significant decline in the sex- and age-adjusted rate of
CrCl tests performed (Po0.0001).
DISCUSSION
The 2002 K/DOQI guidelines are a well-respected and widely
distributed set of clinical practice guidelines, which have had
an important role in changing CKD management. Never-
theless, in our analysis, these guidelines did not have their
intended effect on the rate of CrCl collection. Instead, the
eventual drop in CrCl rates occurred after eGFR reporting
with prompts was implemented in 2006. This change in
CrCl rates parallels the findings in previous studies, which
showed that eGFR reporting with prompts was associated
with increased nephrology consults.11 These referrals were
particularly increased for women, the elderly, and patients
with stage 3 or higher CKD.8
The poor response to the publication of renal guidelines
is not surprising and has been seen in other settings.6,9
Rather, eGFR reporting with prompts may have produced a
clinical practice change because it is integrated directly into
physician workflow.13 Although we acknowledge that the
K/DOQI guidelines were an important ‘first step’ in changing
practice, we suggest that future iterations of guidelines be
accompanied by additional educational or structural changes
that allow for effective knowledge translation.2
The decrease in CrCl tests has had multiple benefits. For
patients, there is reduced burden as they no longer have to
complete cumbersome timed urine collections. At a cost of
$10.35 per CrCl collection,14,15 the decreased number of CrCl
tests represents a cost savings of $243,000 in the 43 months
following eGFR reporting implementation. This is when the
observed number of tests is compared with the projected
number for the time period. Finally, eGFR also better
estimates a patient’s true renal function, facilitating appro-
priate patient management.10,16
The strengths and limitations of this study merit
discussion. We have analyzed a large and diverse patient
population that strengthens the generalizability of our results.
The post-intervention periods were almost 4 years for the
K/DOQI and eGFR analyses, respectively. Increasing the
length of the post-intervention periods would allow us to
better understand longer-term effects. This is particularly
pertinent as previous studies have shown that eGFR reporting
may not be associated with sustained changes in health
services delivery.17,18 Our study is limited by its observational
nature; however, given the natural experiment of the
interventions, time-series analysis is a robust design.19 Our
analysis is also limited by the assumption that most CrCl tests
were ordered to assess renal function, recognizing that other
indications for CrCl, such as the evaluation of kidney stone
risk or other metabolite abnormalities, exist. Finally, the
K/DOQI guidelines are American based. However, in the
absence of comprehensive Canadian eGFR guidelines, we
believe that many Canadian physicians rely on these guide-
lines to aid in treatment of their patients. In fact, the
Canadian Society of Nephrology position paper on CKD
makes reference to the K/DOQI guidelines.12
Given the observed effect of eGFR reporting with
prompts on CrCl tests, laboratory-based reporting may be
a suitable medium to influence clinical practice and could be
used as an adjunct method to improve guideline uptake and
dissemination.
MATERIALS AND METHODS
In Ontario, Canada, a single provincial government payer provides
universal access to health care, including inpatient, outpatient,
diagnostic, and laboratory services, to around 13 million indivi-
duals. Using previously described methods,8,11,20 we used linked
health-care databases to acquire demographic and laboratory usage
data for outpatients over the age of 25 years. This age was chosen to
exclude pediatric patients who were in the process of transitioning
to adult care. Individuals without valid health-card numbers were
excluded, as were patients on chronic dialysis or who had received a
renal transplant in the previous 4 years. We used intervention
analysis with autoregressive integrated moving average modeling
to determine the impact of the following interventions on the rate
of CrCl collection: (1) the publishing of K/DOQI guidelines and
(2) the province-wide introduction of eGFR reporting with asso-
ciated prompts. We modeled these interventions as step functions
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Figure 1 |Monthly number of 24-h creatinine clearance tests
in Ontario (adjusted for sex and age). eGFR, estimated
glomerular filtration rate; K/DOQI, Kidney Disease Outcomes
Quality Initiative.
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without decay (for K/DOQI guidelines) and with decay (for eGFR
reporting). A 3-month lag period between cause and observable
effect was assumed in the eGFR reporting model.
The study period was from August 1999 to July 2009. We applied
intervention analyses in February 2002 to assess the impact of
publishing the K/DOQI guidelines, and in January 2006 for the
introduction of eGFR reporting. We collected the sex- and age-
adjusted CrCl collection rates and patient demographics for each
month. The K/DOQI guideline analysis used 31 pre-intervention
periods and 46 post-intervention periods, whereas the eGFR
reporting analysis had 77 pre-intervention periods and 43 post-
intervention periods. Exclusion criteria included patients younger
than 25 years or patients on dialysis. Analyses were performed using
R version 2.11.1 (R Foundation for Statistical Computing, Vienna,
Austria) and SAS Version 9.2 (SAS Institute, Cary, NC).
DISCLOSURE
YKK received funding from the Schulich Research Training Program,
University of Western Ontario to complete this work.
AXG is supported by a Clinician Scientist Award from the Canadian
Institutes of Health Research (CIHR). AKJ is supported
by a Health Professional Research Fellowship from the CIHR and
by The Academic Medical Organization of Southwestern Ontario.
The opinions, results, and conclusions reported in this paper are
those of the authors, and are independent from the funding sources.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at
http://www.nature.com/ki
REFERENCES
1. Steinbrook R. Guidance for guidelines. N Engl J Med 2007; 356: 331–333.
2. Cabana MD, Rand CS, Powe NR et al. Why don’t physicians follow clinical
practice guidelines? A framework for improvement. JAMA 1999; 282:
1458–1465.
3. Lomas J, Anderson GM, Domnick-Pierre K et al. Do practice guidelines
guide practice? The effect of a consensus statement on the practice of
physicians. N Engl J Med 1989; 321: 1306–1311.
4. Timmermans S, Mauck A. The promises and pitfalls of evidence-based
medicine. Health Aff (Millwood) 2005; 24: 18–28.
5. Aghaie-Jaladerany H, Cowell D, Geddes CC. The early impact of the
United Kingdom Chronic Kidney Disease (CKD) guidelines on the number
of new attendances at renal clinics. Scott Med J 2007; 52: 28–31.
6. Arenas MD, Alvarez-Ude F, Gil MT et al. Application of NKF-K/DOQI
Clinical Practice Guidelines for Bone Metabolism and Disease: changes
of clinical practices and their effects on outcomes and quality standards
in three haemodialysis units. Nephrol Dial Transplant 2006; 21: 1663–1668.
7. American Society of Nephrology. Implementing chronic kidney disease
guidelines (CKD) and eGFR reporting reduces late referral for renal
replacement therapy (RRT). American Society of Nephrology Conference
Proceedings; Philadelphia 2008.
8. Kagoma YK, Weir MA, Iansavichus AV et al. Impact of estimated GFR
reporting on patients, clinicians, and health-care systems: a systematic
review. Am J Kidney Dis 2011; 57: 592–601.
9. Wald R, Tentori F, Tighiouart H et al. Impact of the kidney disease
outcomes quality initiative (KDOQI) clinical practice guidelines for bone
metabolism and disease in a large dialysis network. Am J Kidney Dis
2007; 49: 257–266.
10. National Kidney Foundation. K/DOQI clinical practice guidelines for
chronic kidney disease: evaluation, classification, and stratification.
Am J Kidney Dis 2002; 39: S1–266.
11. Jain AK, McLeod I, Huo C et al. When laboratories report estimated
glomerular filtration rates in addition to serum creatinines, nephrology
consults increase. Kidney Int 2009; 76: 318–323.
12. Levin A, Mendelssohn D. Care and referral of adult patients with reduced
kidney function: position paper from the Canadian Society of
Nephrology. Canadian Society of Nephrology ohttp://www.csnscn.ca/atf/
cf/%7Bfd785d1c-e27a-489e-be3a-c75d43a753f1%7D/CSN%20POSTION%
20PAPER%20SEPT2006.PDF4, accessed on 22 August 2009.
13. Kawamoto K, Houlihan CA, Balas EA et al. Improving clinical practice
using clinical decision support systems: a systematic review of trials to
identify features critical to success. BMJ 2005; 330: 765.
14. MacDonald J. Cost of creatinine clearance test. LifeLabs Inc, 2010
(personal communication).
15. Ontario Ministry of Health and Long-Term Care. Ontario health insurance
(OHIP) schedule of benefits for laboratory services. Ontario Ministry of
Health and Long-Term Care ohttp://www.health.gov.on.ca/english/
providers/program/ohip/sob/lab/lab_mn.html4, accessed 8 August 2010.
16. Johnson DW, Jones GR, Becker GJ et al. Automated reporting of eGFR:
a useful tool for identifying and managing kidney disease. Med J Aust
2009; 190: 200–203.
17. Jain AK, Akbari A, Cuerden MS et al. eGFR reporting increased the use
of kidney protective medications in the population of Southwestern
Ontario with CKD. American Society of Nephrology Conference Proceeding,
San Diego, 2009.
18. Patel V, Yalavarthy U, Desbiens NA. Does reporting estimated glomerular
filtration rate affect ordering of timed urine collections? Am J Med Sci
2009; 337: 185–187.
19. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd edn.
Lippincott Williams & Wilkins: Philadelphia, 2008.
20. Mamdani M, Juurlink DN, Lee DS et al. Cyclo-oxygenase-2 inhibitors
versus non-selective non-steroidal anti-inflammatory drugs and
congestive heart failure outcomes in elderly patients: a population-based
cohort study. Lancet 2004; 363: 1751–1756.
Kidney International (2012) 81, 1245–1247 1247
YK Kagoma et al.: Laboratory effects of K/DOQI guidelines and eGFR reporting o r ig ina l a r t i c l e
